Overview

Study of Erythromycin in GER-Associated Apnea of the Newborn

Status:
Unknown status
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the relationship of reflux and apnea and to determine whether the administration of erythromycin improves the incidence of GER and GER-associated apnea, bradycardic and/or desaturation events in a prospective randomized controlled trial.
Phase:
N/A
Details
Lead Sponsor:
University of Virginia
Treatments:
Erythromycin
Erythromycin Estolate
Erythromycin Ethylsuccinate
Erythromycin stearate
Phenobarbital